Release Date: 28/05/18 10:47 Summary: Notice of Meeting (Section 249D) Price Sensitive: No Download Document 524.53KB Download
RBL Recce Pharmaceuticals advances global reach with Indonesia’s approval for Phase 3 Diabetic Foot Infection Trial